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The study first evaluated the hepatoprotective effect of Zhuyeqing Liquor (ZYQL) against acute alcohol-induced
liver injury in mice. Animals were administered orally with 50% alcohol 12 ml/kg at 4 h after the doses of ZYQL
everyday for fourteen consecutive days except mice in normal group. The protective effect was evaluated by
biochemical parameters including serum aspartate transaminase (AST), alanine transferase (ALT), total-bilirubin (TBIL)
and reduced glutathione (GSH), malondialdehyde (MDA), superoxide dismutase (SOD) in liver tissue. The result were
confirmed histopathologically and the expression of TNF-α in mice liver was determined by immunohistochemistry
analysis. HPLC-PDA was used for phytochemical analysis of ZYQL, and the plant source of each compound was claritied
by UPLC-TOF-MS. The result showed that pretreatment with ZYQL exhibited a significant protective effect by reversing
the biochemical parameters and histopathological changes in a dose depended manner. HPLC analysis indicated that
ZYQL contained flavonoids, iridoids, terpenoids and phenolic acids, which might be the active chemicals. This study
demonstrated the hepatoprotective activity of ZYQL, thus scientifically supported the function of its health care.
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Alcohol is a dietary component which is usually con-
sumed for its psychophysical and mood-altering effects.
However, long-term alcohol consumption may cause
damage to vital organs including gastrointestinal, cardio-
vascular, endocrine and central nervous systems [1,2],
especially the liver disease which has become a social
problem. In China, the incidence of alcoholic liver dis-
ease (ALD) has increasing and becoming an important
risk factor for morbidity and mortality in addition to
viral hepatitis [3], due to the increased frequency of
drinking and change of diet construction. Drugs includ-
ing bifendate, tiopronin and bicyclol have been reported
to have protective effect against ALD, however, definite
treatment strategies for ALD remain undefined. Hence,
prevention of ALD is a therapeutic challenge and* Correspondence: wjh.1972@aliyun.com; liguoyulisa@163.com
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reproduction in any medium, provided the ordeveloping inexpensive natural agents which possesses
the hepatoprotective effects can achieve the goal is fur-
ther a higher challenge, and also has become the focus
of research in recent years.
Zhuyeqing Liquor (ZYQL) is a famous traditional
Chinese functional liquor comprising twelve crude
drugs: Lophatherum gracile Brongn. (Zhuye), Gardenia
jasminoides Ellis (Zhizi), Lysimachia capillipes Hemsl.
(Paicao), Angelica sinensis (Oliv.) Diels (Danggui),
Kaempferia galanga L. (Shannai), Citrus reticulata
Blanco (Chenpi), Chrysanthemum morifolium Ramat.
(Juhua), Amomum villosum Lour. (Sharen), Santalum
album L. (Tanxiang), Eugenia caryophyllata Thunb.
(Dingxiang), Aucklandia lappa Decne. (Muxiang),
Lysimachia foenum-graecum Hance (Linglingxiang). This
formula could trace back to the Warring States Period
and it became popular among people in the South and
North Dynasty. With the rapid social development,
it had reached its climax in Tang Dyansty and Song
Dynasty, and has been formally authorized as a func-
tional health liquor in 1998 by Ministry of Public Health. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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biological properties like anti-oxidant, anti-fatigue and
immunoenhancement [4], and some reports also showed
that most of the medical herbs it contains have the effect
of hepatic injury protection [5], blood coagulation, anti-
tumor, anti-inflammation, gastrointestinal protection,
immunity regulation, anti-oxygen etc. [6-9] and some
which have been used in TCM formulation on clinical
practice for their hepatoprotective effects. Our labora-
tory has identified the main components in ZYQL
through systematically chemical isolation and detected
by HPLC-PDA detectors in previous study. These main
components of ZYQL was also claritied its plant source
by UPLC-TOF-MS. However, there is no pharmaco-
logical study for the hepatoprotective effect of ZYQL
yet, scientific literature data supporting the health func-
tion of ZYQL in ALD are unavailable and its tentative
mechanisms are still unknown. Herein, evaluating the
hepatoprotective effect and identifying the active group
of ZYQL are important in revealing the therapeutic ma-
terial basis, providing the evidence for the pharmaco-
logical effect and improving the quality control of this
health liquor.
In view of that, the present study was conducted to in-
vestigate the potential protective effects of feeding ZYQL
on alcohol-induced liver injury in mice. The study also




Methanol and formic acid (HPLC grade) was purchased
from Fisher Scientific Co. (Franklin, USA). Phosphoric
acid (analytical grade) was purchased from Tianjin
Guangfu Chemical Reagent Co. Ltd. (Tianjin, China).
Water was prepared using a redistilled water equipment.
Ethanol and other chemicals used were all of analytical
grade and from Nanjing Chemical Co.(Nanjing China).
Alanine aminotransferase (ALT), aspartate aminotrans-
ferase (AST), total bilirubin (TBIL), glutathione (GSH),
superoxide dismutase (SOD) and malondialdehyde (MDA)
kits were obtained from Nanjing Jiancheng Bioengineering
Institute (China). Protein assay kit was from Zhongshan
Institute of Biotechnology (Beijing, China). Antibodies
against TNF-α was purchased from abcam Biotechnology
(abcam, UK), All other chemicals used in these experi-
ments were of analytical grade and were obtained from
commercial sources (Beijing, China).
The reference standard of 1–35 was isolated previously
from Zhuyeqing Liquor by author, structures of which
were elucidated by comparison of spectral data (UV, MS,
1H NMR and 13C NMR) with the literature data (see
Additional file 1: page S7, Reference). The purity of each
reference standard was determined to be above 98%.Bifendate drop pill (1.5 mg bifendate per pill) was pro-
vided by Beijing Union Pharmaceutical Plant.
Zhuyeqing Liquor (amber powder) was provided by Shanxi
XinghuaCun Fen Jiu Group Co., Ltd. (Shanxi Province,
China), The voucher specimen was deposited at Shenyang
Pharmaceutical University (Shenyang, China) and registered
under the number ZYQL 2011050101. Proper amount of
Zhuyeqing liquor were evaporated in vacuum at 50°C to dry-
ness. The dry residues was dissolved in sterilized distilled
water before oral administration to the experimental ani-
mals. All doses given are the gramweight of the administered
ZYQL powder in sterilized distilled water.
HPLC analysis
ZYQL was analyzed using HPLC-PDA, proper amount
of dry residues were dissolved with 70% ethanol to pre-
cipitate the polysaccharide in order to obtain better ana-
lytical results, then samples were filtrated through a
0.45 μm membrane filter. HPLC analysis was performed
on a Waters 2695 Alliance HPLC system with Waters
2998 PDA detector.
Chromatographic analysis was performed on a SHI-
MADZU VP-ODS column (150 mm× 4.6 mm I.D. 5 μm).
The mobile phase was methanol (A) and 0.1% Phosphoric
acid (B). A gradient programmer was used according to the
following profile: 0 min 5% A, 67 min 55% A, 75 min 60%
A, 110 min 80% A, 120–125 min 98% A, 127–140 min 5%
A. A constant flow rate of 1.0 ml/min was maintained
through out the analysis. The column temperature was set
to 25°C. Peaks were detected at 254 nm of PDA detection.
UPLC-TOF-MS analysis
Waters UPLC-TOF-MS (Waters ACQUITY UPLC™ sys-
tem tandem Waters LCT Premier XE TOF-MS, Software
version: Mass Lynx V4.1) was used for the qualitative ana-
lysis. Chromatographic separation was carried on a
ACQUITY UPLC BEH C18 (2.1 mm× 50 mm, 1.7 μm) at
30°C. Mobile phase was composed of acetonitrile (A) and
1% formic acid-water (B). The gradient program was as
follows: 0–2.00 min, 30-95% A; 2.00-6.50 min, 95-95% A;
6.50-6.70 min, 95-30% A; 6.70-8.00 min, 30% A. The flow
rate of mobile phase was set at 0.2 mL/min. The injection
volume was 2 μL. For the MS analysis, nitrogen was used
as desolvation gas at flow rates of 400 L/h for both ESI (+)
and ESI (−). The cone gas flow rate was set at 10 L/h. The
desolvation temperature was fixed at 200°C. The source
temperature was set at 100°C. Capillary voltage was
2600 V for ESI (+) and 1800 V for ESI (−). The spectra
were recorded in the range of m/z 100–1500 for full scan.
Animals
Male Kunming strain mice (18 ± 2 g) were obtained from
Experimental Animal Center of Shenyang Pharmaceutical
University, China. The animals were housed for one week
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conditions were as follows: light (12 h light/dark cycle),
temperature (24 ± 1°C), humidity (50 ± 5%), free access to
food and water. The use of these animals was approved by
the institute ethnics committee of Shenyang Pharmaceut-
ical University. And the studies reported in this manu-
script were carried out strictly in accordance with the
guide for the care and use of laboratory animals (National
Research Council of USA, 1996) and related ethical regu-
lations of Shenyang Pharmaceutical university.
Experimental design
After 1 week acclimatization, the animals were randomly di-
vided into six equal groups as follows: normal control group,
alcohol group, three groups for the high dose, medium dose
and low dose of ZYQL and the positive control group for
bifendate, each experimental group consisted of 12mice.
For ZYQL treated group, the daily doses of ZYQL
(high dose, medium dose and low dose) were 200, 100
and 50 mg/kg, respectively, other groups received an
equal volume of vehicle as control. For positive control
group, mice were received 150 mg/kg bifendate. By re-
ferring to related literatures about the dose of animal
[10-12], all animals were administered orally with 50%
alcohol 12 ml/kg at 4 h after the doses of ZYQL and
bifendate, respectively everyday except mice in normal
control group for fourteen consecutive days. Six hours
after the last alcohol treatment, blood was first obtained
from the animal through the orbital venous plexus, using
capillary tubes, blood was allowed to clot and the serum
was separated by centrifugation at 3000 rpm for 10 min
at 4°C, and then stored at −80°C. Serum was used to
analyze activity of liver enzymes ALT, AST and TBIL.
Then, all the animals were sacrificed by cervical decapi-
tation to obtain the liver for histopathological, immuno-
histochemical and biochemical assays.
Biochemical assays
Measurement of liver function markers
Serum alanine aminotransferase (ALT), aspartate amino-
transferase (AST) and TBIL (total bilirubin) were mea-
sured using Olympus kits (Olympus Corp., Tokyo,
Japan) in an Olympus AU 600 Autoanalyzer. The obser-
vation absorbance of ALT and AST were read at 505 nm
and the enzyme activity was calculated as U/L. The ob-
servation absorbance of TBIL was read at 600 nm and
the content was calculated as μmol/L.
Measurement of malondialdehyde (MDA) formation in lipid
peroxidation
The anti-lipid peroxidation was estimated by the method
of Ohkawa (1979). Liver homogenate (10%, w/v) was pre-
pared by homogenizing the liver tissue in 150 mM Tris–
HCl buffered saline (pH 7.2) with a polytron homogenizer.The level of MDA in liver tissues was measured with a
spectrophotometer (Hitachi U-2001) at 532 nm. The pro-
tein content was determined by the method of Lowry
(1951). and the data are expressed as nmol MDA per
milligram of protein of liver tissue (nmol/mg protein).
Measurement of hepatic GSH level
The measurement of GSH was conducted by modified
protocol provided by GSH kit from Jiancheng Biological
Engineering Institute (Nanjing, China). The observation
absorbance of the reaction was read at 420 nm and the
enzyme activity was calculated as mg/g protein.
Measurement of hepatic SOD activity
SOD activity was determined as described by Beauchamp
(1971) by measuring its ability to inhibit the photochem-
ical reduction of nitro blue tetrazolium (NBT) in absorb-
ance at 550 nm. Following the commercial kit protocol
provided by Jiancheng Biological Engineering Institute
(Nanjing, China), Data was expressed as SOD units/mg
protein as compared with the standard.
Histopathological observation
Mice liver specimens were fixed with 10% formaldehyde
and processed routinely for embedding in paraffin, cut
into 5 μm thick sections, stained with hematoxylin-eosin
(H&E) for routine histopathological examination, and
then examined under the light microscope.
Immunohistochemistry analysis
Formalin-fixed, paraffin-embedded sections (5 μM) were
mounted on glass slides. Sections were deparaffinized,
incubated in 3% H2O2 for 10 min to quench endogenous
peroxidase activity. After blocking with normal goat
serum for 20 min, the sections were stained with poly-
clonal rabbit anti-TNF-α antibody at 4°C overnight re-
spectively, followed by incubation with horseradish
peroxidase-conjugated goat anti-rabbit antibody at 37°C
for 30 min. The antibody biding sites were visualized by
incubation with DAB-H2O2 at room temperature for
10 min. Images were taken at original magnification of
200× (Olympus BX-50 Microscope, Japan and Leica
DMIL, Leica Microsystems, Germany).
Statistical analysis
Results were expressed as mean ± S.D. and all statistical
comparisons were made by means of a one-way ANOVA
test followed by Dunett’s t-test. p < 0.05 and <0.01 were
considered statistically significant.
Results
HPLC profiles of Zhuyeqing liquor
The main compounds of ZYQL were analyzed with
HPLC. The HPLC chromatogram and the representative
Figure 1 Chromatograms of Zhuyeqing Liquor (ZYQL) and the standard reference. (A) HPLC-PDA chromatogram of ZYQL monitored at
254 nm; (B) HPLC-PDA chromatogram of standard reference monitored at 254 nm. (C) Representative UPLC-TOF-MS positive ion mode
chromatogram (From up to down: Compound 33, Zhizi, Shannai, Zhuyeqing Liquor).
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in Figure 1 (A, B, C). By referring to standards, the chroma-
tographic analysis showed the main components of ZYQL
were 3-hydroxy-4,5(R)-dimethyl-2(5H)-furanone (1), (E)-2-
hydroxy-3-methyl-penta- 3-enioc acid (2), protocatechuic
aldehyde (3), picrocrocinic acid (4), isobiflorin (5), vanillic
acid (6), biflorin (7), genipin 1-O-β-D-gentiobioside (8),
1-sinapoyl-β-D-glucopyranoside (9), geniposide (10),
epijasmnoside A (11), kaempferol (12), rehmapicrogenin
(13), ferulic acid (14), luteolin-8-C-β-glucopyranoside (15),isoorientin (16), narirutin (17), 10-O-acetylgeniposide (18),
isorhamnetin-3-O-rutinoside (19), hesperidin (20), 6″-O-
trans-p-coumaroyl genipin gentiobioside (21), 6″-O-cis-p-
coumaroyl genipin gentiobioside (22), 2α-hydroxy oleanolic
acid (23), 6′-O-(3-methoxyl caffeoyl)-epijasminoside B
(24), 6′-O-sinapoylgeniposide (25), cis-p-coumaric acid
ethyl ester (26), methyl 5-O-caffeoyl-3-O-sinapoylquinate
(27), trans-p-coumaric acid ethyl ester (28), 3′,4′,5,6,7-
pentamethoxyl flavone (29), 3,5-dihydroxy-3′,4′,7,8-tetra-
methoxyl flavone (30), 5-hydroxy-4′,6,7,8-tetramethoxyl
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3′,4′,3,5,6,8-hexamethoxyl flavone (33), kaempferide (34),
oleanolic acid (35). (Structures of compound 1–35 see
Additional file 1: Figure S1. Plant source and chromato-
graphic analysis of these components were shown in
Additional file 1: Table S1).
General observation
All mice behaved excited except the normal group after
administered orally with 50% alcohol 12 ml/kg, then
showed unsteadily walking and accelerated breathing.
Less activity was observed after 2–3 days. On the 14th
day, mortality was observed in all groups except the
normal group, and the group of ZYQL (200 mg/kg)
exhibited the lowest death rate.
Effect of ZYQL on organ coefficient
Liver, spleen and kidney coefficients were evaluated
in mice. Compared to the control group, liver coeffi-
cients of alcohol group was significantly increased in
mice (p < 0.05, Table 1); In contrast, there was no signifi-
cant difference in spleen and kidney coefficient among
all treated groups. As demonstrated in Table 1, the in-
crease of liver coefficient caused by alcohol treatment in
mice was reduced by ZYQL (200 mg/kg) and Bifendate
(150 mg/kg), respectively (p < 0.01, p < 0.05, Table 1),
and dose-effect correlation was observed in ZYQL
groups regarding to the increase of liver coefficient by
alcohol treatment. These results are presented in
Table 1.
Effect of ZYQL on ALT, AST and TBIL levels
The serum activities of ALT, AST and TBIL were used
as biochemical markers for the early acute hepatic dam-
age. In Table 2, serum ALT, AST and TBIL were in-
creased by 2.04-, 2.20- and 3.20- fold, respectively over
those in normal mice after administration of alcohol on
the 14th day. Pretreatment with 50, 100 and 200 mg/kg
of ZYQL significantly reduced the elevation of ALT,
AST and TBIL (p < 0.01, p < 0.05) and in a dose-Table 1 Effect of ZYQL on organ coefficient in acute alcohol-i
Groups Dose(mg/kg) Liver coefficient%
Control - 4.41 ± 0.53
Alcohol - 5.14 ± 0.27a
ZYQL-High 200 4.29 ± 0.83c
ZYQL-Medium 100 4.56 ± 1.02
ZYQL-Low 50 4.58 ± 0.82
Bifendate 150 4.40 ± 0.35b
Values represent the mean ± S.D. The one-way ANOVA was performed on the raw
aSignificant difference at p < 0.05 levels compared with the control group.
bSignificant difference at p < 0.05 levels compared with alcohol treated group.
cSignificant difference at p < 0.01 levels compared with alcohol treated group.dependent manner. Bifendate pretreatment also offered
significant (p < 0.01) protection against acute alcohol-
intoxicated mice by attenuating ALT, AST and TBIL ele-
vation (Table 2).
Effect of ZYQL on MDA, GSH and SOD levels
MDA is an end-product of the breakdown of polyunsatur-
ated fatty acids and related esters, and its formation is an
index of lipid peroxidation in many organ homogenate
[13]. As shown in Table 3, the levels of hepatic MDA
significantly increased in alcohol group (p < 0.01), alcohol-
induced elevation of tissue MDA concentration was
lowered significantly (p < 0.01, p < 0.05) by pretreated with
ZYQL (50, 100 and 200 mg/kg) with a dose-dependent
manner (7.58 ± 1.79, 5.63 ± 1.11 and 4.41 ± 1.23). Hepatic
GSH and SOD levels were decreased after alcohol
treatment (p < 0.01, Table 3). Pretreatment with ZYQL
(100 and 200 mg/kg) exhibited protection against alcohol-
induced hepatic GSH and SOD depletion. The low dose of
ZYQL (50 mg/kg) showed obvious protective effect
against alcohol-induced decrease of SOD levels (p < 0.05),
while no obvious effect on GSH.
Histopathological studies
Observed by naked eyes, the livers of vehicle control
group were deep red, moist, glossy and resilient. In alco-
hol group, the livers lost luster and yellow necrosis foci
were often found on the surface. Liver injury of ZYQL
pretreated mice was attenuated dramatically in a dose-
dependent manner (Additional file 1: Figure S2).
The histological features under light microscope, as
shown in Figure 2A, indicated a normal liver lobular
architecture and cell structure of the livers in the control
animals, which showed that the liver lobular structures
were clear and regular, and single layer of hepatocytes
arranged around the central vein in a radical pattern and
there were abundant basophilic granular cytoplasms in the
hepatocytes. In alcohol treated group, normal liver lobular
structures were damaged and collapsed. The hepatocytes
showed vacuolization, sinusoidal dilation and congestion.nduced liver injury in mice
Kidney coefficient% Spleen coefficient%
1.46 ± 0.16 0.22 ± 0.07
1.40 ± 0.17 0.29 ± 0.11
1.45 ± 0.15 0.23 ± 0.05
1.46 ± 0.13 0.24 ± 0.07
1.44 ± 0.09 0.27 ± 0.03
1.40 ± 0.06 0.28 ± 0.04
data.
Table 2 Effect of ZYQL on ALT, AST and TBIL levels in acute alcohol-induced liver injury in mice
Groups Dose(mg/kg) ALTd ASTd TBILe
Control - 32.34 ± 8.81 44.81 ± 19.48 6.76 ± 0.73
Alcohol - 66.03 ± 15.02a 98.73 ± 18.29a 21.62 ± 2.03a
ZYQL-High 200 33.30 ± 9.40c 47.47 ± 9.09c 6.33 ± 1.95c
ZYQL-Medium 100 34.85 ± 8.12c 50.55 ± 11.07c 9.84 ± 1.45c
ZYQL-Low 50 46.16 ± 6.92b 65.16 ± 10.33b 12.59 ± 1.40b
Bifendate 150 24.74 ± 5.30c 47.27 ± 8.95c 6.96 ± 1.41c
Values represent the mean ± S.D. The one-way ANOVA was performed on the raw data.
aSignificant difference at p < 0.01 levels compared with the control group.
bSignificant difference at p < 0.05 levels compared with alcohol treated group.
cSignificant difference at p < 0.01 levels compared with alcohol treated group.
dIU/L.
eμmol/L.
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ies were also observed (Figure 2B). Histopathologcial
changes induced by alcohol were remarkably improved by
ZYQL, the high dose of ZYQL alleviated the lipid change
of hepatocytes (Figure 2C), showing obvious difference
from the model group and similar to bifendate group
(Figure 2F).
Immunohistochemistry analysis
Varying degrees of TNF-α expression were seen in the dis-
eased liver tissues. The normal control group exhibited
minimal TNF-α expression (Figure 3A), whereas all ex-
perimental groups showed increased expression of TNF-α,
especially in the alcohol-intoxicated group (Figure 3B).
After pretreatment with ZYQL (50, 100 and 200 mg/kg),
TNF-α expression shows decrease but it is still higher than
normal group (Figures 3C, D, E). While similar to previous
study, pretreatment with Bifendate (150 mg/kg), an agent
being applied clinically to treat liver disease, abolishes the
positive signals of TNF-α (Figure 3F).
Discussion
Alcohol-induced liver injury, one of the most common
causes of liver diseases worldwide, has been paid moreTable 3 Effect of ZYQL on MDA, SOD and GSH levels in acute
Groups Dose(mg/kg) MDAd
Control - 3.72 ±
Alcohol - 9.04 ±
ZYQL-High 200 4.41 ±
ZYQL-Medium 100 5.63 ±
ZYQL-Low 50 7.58 ±
Bifendate 150 4.60 ±
Values represent the mean ± S.D. The one-way ANOVA was performed on the raw d
aSignificant difference at p < 0.01 levels compared with the control group.
bSignificant difference at p < 0.05 levels compared with alcohol treated group.
cSignificant difference at p < 0.01 levels compared with alcohol treated group.
dnmol/mgprot.
eU/mgprot.
fmg/gprot.attention and which presents initially as acute inflamma-
tion then progresses to fatty liver, alcoholic hepatitis and
ultimately to fibrosis and cirrhosis [14]. Binge alcohol
drinking is a more potent health hazard caused due to
bulk intoxication of alcohol at a single go. However,
presently there is no universally accepted therapy avail-
able to halt or reverse this process in humans [15]. Thus,
more attention has been paid to the research and devel-
opment of effective therapy for ALD and agents for
protecting alcohol-induced liver injury. At present, it has
been recognized that oxidative stress and generation of
free radicals play a critical role in the development of
ALD. Therefore, some natural products with antioxidant
activity have attracted great attention as potential func-
tional ingredients to protect alcohol-induced liver injury
[16,17].
In China, ZYQL as a functional health liquor has been
exist for more than a millennium, and the long time his-
tory use of ZYQL has been proved that drinking of ZYQL
could improve body immunity. Moreover, recent reports
also suggest that ZYQL has the functions of anti-oxidation,
anti-fatigue and body immunoenhancement [4]. How-
ever, whether ZYQL could alleviate the damage comes
from liquor drinking is not clear. Thus, in the presentalcohol-induced liver injury in mice
SODe GSHf
1.09 301.68 ± 24.93 4.34 ± 1.33
1.48a 188.30 ± 22.89a 0.85 ± 0.30a
1.23c 290.56 ± 15.13c 3.73 ± 1.53c
1.1 c 255.49 ± 12.16c 2.02 ± 1.10b
1.79b 215.86 ± 6.41b 1.64 ± 0.70
0.97c 267.56 ± 26.13c 2.58 ± 0.91c
ata.
Figure 2 Hepatoprotective effect of Zhuyeqing Liquor on Alcohol-induced hepatotoxicity in mice. Liver sections were stained with
haematoxylin and eosin (×100). (A) Normal control group; (B) Alcohol-induced group; (C), (D) and (E) are Alcohol group treated with 50, 100 and
200 mg/kg of ZYQL, respectively; (F) is Alcohol group treated with 150 mg/kg of Bifendate.
Figure 3 Representative photographs of immunohistochemical localization of TNF-α in mice liver with Alcohol hepatotoxicity (×200).
(A) Normal control group; (B) Alcohol-induced group; (C), (D) and (E) are Alcohol group treated with 50, 100 and 200 mg/kg of ZYQL,
respectively; (F) is Alcohol group treated with 150 mg/kg of Bifendate.
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ZYQL on acute alcohol-induced liver injury in mice. In
this present study, our results confirmed the involvement
of oxidative stress in acute alcohol-induced liver injury
and showed significant protective effect of ZYQL, as
evidenced by decreasing the level of MDA and inhibiting
the decrease of SOD and GSH activity. The attenuation of
acute alcohol-induced oxidative stress by ZYQL was prob-
ably due to its ability to restore the balance between gen-
eration and clearance of ROS. Reduction in the levels of
AST, ALT and TBIL towards the normal value was an in-
dication of the stabilisation of plasmamembrane and the
repair of hepatic tissue. Moreover, Histological examin-
ation of the liver sections revealed lipid change of hepato-
cytes treated with alcohol, while in the sections obtained
from the mice treated with ZYQL and with alcohol, the
lipid change of hepatocytes was alleviated. Thus, these
results suggested that the inhibition of liver function
markers elevation and liver damage may participate in
the protective effect of ZYQL against alcohol-induced
hepatotoxicity.
By using HPLC analysis, we found that the main
components of ZYQL were iridoids, flavonoids, terpe-
noids and phenolic acids. In the study, pretreatment
with ZYQL exhibited a significant decrease in the ele-
vated AST, ALT, and TBIL (p < 0.01, p < 0.05) levels in a
dose-dependent manner, this indicated that ZYQL pre-
treatment offered significant protection against acute
alcohol-intoxicated mice, and can also relieve the dam-
age of alcohol on the cell membrane and mitochondria
membrane. This effect is in agreement with the com-
monly accepted view that serum levels of transaminases
return to normal with the healing of hepatic parenchyma
and regeneration of hepatocytes [18].
Production of ROS during alcohol-induced liver
injury is the major causative factor for the liver damage
[19]. To address this point, experiments were performed
to measure lipid peroxidation (MDA), SOD and GSH
content in liver tissues of the control and the experi-
ment group. Lipid peroxidation (MDA) were signi-
ficantly increased by 2.4-fold in alcohol-treated tissues
as compared to control. Alcohol-treated liver tissue
exhibited 1.6-fold less SOD and 5.1-fold less GSH com-
pared to untreated ones (Table 3). Moreover, pretreat-
ment with ZYQL enhanced the activities of antioxidant
enzyme (SOD), increased the antioxidant content (GSH),
and diminished the amount of lipid peroxide (MDA)
against the alcohol-induced hepatotoxicity in these ani-
mals, suggesting that the activity of antioxidant and de-
creasing the formation of lipid peroxidation may plays a
role in the mechanism of its hepatoprotective effects.
Tumor necrosis factor (TNF-α)-α is a central pro-
inflammatory cytokine, and it has been suggested that
it is important in the development of alcohol inducedliver injury [20]. Because TNF-α is produced predomin-
antly by the monocyte macrophage lineage and the major
population of this lineage in the liver is Kupffer cells [21],
increased production of TNF-α by activated Kupffer cells
may be responsible for alcoholic hepatitis. Recent studies
have shown that inhibition of TNF-α could decrease in
the amount of hepatic fatty storage in alcohol-treated mice
[22]. In the present study, the effects of TNF-α in the
damaged liver was evaluated by immunohistochemistry.
Compared to the control group, treated with alcohol
upregulated the expression of TNF-α, while pretreatment
with ZYQL downregulated the expression of TNF-α com-
pared to the alcohol-intoxicated group.
Recent research findings about the hepatoprotective and
antioxidant effect of components in twelve single herbs of
ZYQL have been reported. Oleanolic acid in Eugenia
caryophyllata Thunb. (Dingxiang), an agent being applied
clinically to treat liver disease, significantly reduced the
serum level of AST and ALT increased by CCl4 intoxica-
tion [23]. Geniposide in Gardenia jasminoides Ellis (Zhizi)
could significantly reduce the level of MDA increased by
alcohol. Sudnikovich et al. reported that flavonoids inhibit
peroxidation by acting as chain breaking peroxyl-radical
scavengers [24]. Kaempferol, luteolin-8-C-β-glucopyra-
noside, isoorientin, narirutin, isorhamnetin 3-O-rutinoside,
hesperidin, 3′,4′,5,6,7-pentamethoxyl flavone, 3,5-dihydro-
xy-3′,4′,7,8- tetramethoxyl flavone, 5-hydroxy-4′,6,7,8-
tetramethoxyl flavone, 3′,4′,5,6,7,8-hexamethoxyl flavone,
3′,4′,3,5,6,8-hexamethoxyl flavone, kaempferide were fla-
vonoids found in Angelica sinensis (Oliv.) Diels (Danggui),
Kaempferia galanga L. (Shannai), Citrus reticulata Blanco
(Chenpi), Chrysanthemum morifolium Ramat. (Juhua) and
Aucklandia lappa Decne. (Muxiang) exhibited antioxidant
activity and increased the metabolism of alcohol according
to the literature reported [8,9,25,26]. Phenolic compounds
are commonly found in both edible and other traditional
medicinal plants, and they have been reported to have mul-
tiple biological activities, including free radical scavenging
activity [27-29]. Protocatechuic aldehyde, vanillic acid,
ferulic acid, cis-p-coumaric acid ethyl ester and trans-p-
coumaric acid ethyl ester were phenolic compounds found
in Lophatherum gracile Brongn. (Zhuye), Amomum villo-
sum Lour. (Sharen), Santalum album L. (Tanxiang) and
Lysimachia foenum-graecum Hance (Linglingxiang) also
exhibited antioxidant and radical scavenging activities [29].
The HPLC, UPLC-TOF-MS analysis and the hepato-
protective effect of ZYQL in our study suggested that the
activity of ZYQL may be related to compounds including
iridoids, flavonoids, terpenoids and phenolic acid from the
twelve single herbs. Therefore, we proposed that iridoids,
flavonoids, terpenoids and phenolic acids may be used for
the quality control of ZYQL. Further research elucidating
the action mechanism of these effects using purified ingre-
dients and single herbs will give an insight into the
Gao et al. Journal of Inflammation 2013, 10:30 Page 9 of 9
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the acute alcohol-induced liver injury.
Conclusion
Taken together, the present study suggests that ZYQL has
a potent hepatoprotective activity in alcohol-induced liver
injury in mice, especially the dose of 200 mg/kg. The en-
hanced levels of antioxidant enzymes, reduced amount of
lipid peroxides, ameliorate hepatic function and the sup-
pression of TNF-α production in liver are suggested to be
the major mechanisms of ZYQL in preventing the devel-
opment of liver damage induced by alcohol. Phytochem-
ical analysis also showed that the mainly active chemical
constitutes in ZYQL included iridoids, flavonoids, terpe-
noids and phenolic acids. Our investigation provided con-
vincing data supporting the potential function of health
care and the quality control of ZYQL.
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